Cargando…

Improving spectacle wear in school children

Detalles Bibliográficos
Autores principales:	Morjaria, Priya, Raj, P Dinesh, Murthy, GVS
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Centre for Eye Health 2017
Materias:	Prescribing Spectacles for Children
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5646580/ https://www.ncbi.nlm.nih.gov/pubmed/29070924

Ejemplares similares

Use of ready-made spectacles in school eye health programmes
por: Morjaria, Priya
Publicado: (2017)

Animation sur la lumière
por: GAUMER, Olivier
Publicado: (2015)

Drôle de Physique
por: PONCE, Sebastien
Publicado: (2015)

Opening Ceremony
por: CERN. Geneva
Publicado: (2012)

General Assembly
por: Stevens, Jeremy
Publicado: (2012)

General Assembly
por: Stevens, Jeremy
Publicado: (2012)

Closing Ceremony
por: Stevens, Jeremy
Publicado: (2012)

FAMELAB SWISS SEMI FINALS
por: CERN. Geneva
Publicado: (2013)

Seeing the Invisible
por: Peters, Jan, et al.
Publicado: (2013)

Spectacle wearing in children randomised to ready-made or custom spectacles, and potential cost savings to programmes: study protocol for a randomised controlled trial
por: Morjaria, Priya, et al.
Publicado: (2016)

Effectiveness of a novel mobile health (Peek) and education intervention on spectacle wear amongst children in India: Results from a randomized superiority trial in India
por: Morjaria, Priya, et al.
Publicado: (2020)

Compliance of spectacle wear among school children
por: Gajiwala, Uday R, et al.
Publicado: (2021)

Improving adherence with eye medication: a patient-centred approach to prescribing
por: Wiafe, Boateng, et al.
Publicado: (2023)

Effectiveness of a novel mobile health education intervention (Peek) on spectacle wear among children in India: study protocol for a randomized controlled trial
por: Morjaria, Priya, et al.
Publicado: (2017)

Eligibility for the use of ready-made spectacles among children in a school-based programme in Ghana
por: Asare, Frederick Afum, et al.
Publicado: (2022)

Erratum to: Effectiveness of a novel mobile health education intervention (Peek) on spectacle wear among children in India: study protocol for a randomized controlled trial
por: Morjaria, Priya, et al.
Publicado: (2017)

Rucaparib and Niraparib in Advanced Ovarian Cancer
por: Redelico, Tyler
Publicado: (2019)

Alpelisib: A Novel Therapy for Patients With PIK3CA-Mutated Metastatic Breast Cancer
por: Wilhoit, Tori, et al.
Publicado: (2020)

Polatuzumab Vedotin for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma in Transplant-Ineligible Patients
por: Douglas, Melanie
Publicado: (2020)

Letermovir for Cytomegalovirus Prevention in Patients Undergoing Hematopoietic Cell Transplantation
por: Daniels, Kori, et al.
Publicado: (2019)

A Review of PI3K Inhibitors in B-Cell Malignancies
por: Cannon, Laura, et al.
Publicado: (2019)

Mogamulizumab-kpkc: A Novel Therapy for the Treatment of Cutaneous T-Cell Lymphoma
por: Watson, Sutton, et al.
Publicado: (2019)

Axicabtagene Ciloleucel: The First FDA-Approved CAR T-Cell Therapy for Relapsed/Refractory Large B-Cell Lymphoma
por: King, Amber C., et al.
Publicado: (2019)

Gilteritinib: A Novel FLT3 Inhibitor for Relapsed/Refractory Acute Myeloid Leukemia
por: Marjoncu, Dennis, et al.
Publicado: (2020)

Ribociclib and Abemaciclib: CDK4/6 Inhibitors for the Treatment of Hormone Receptor–Positive Metastatic Breast Cancer
por: Byers, Kristina F.
Publicado: (2021)

Ivosidenib: IDH1 Inhibitor for the Treatment of Acute Myeloid Leukemia
por: Merchant, Shelby L., et al.
Publicado: (2019)

Apalutamide for the Treatment of Nonmetastatic Castration-Resistant Prostate Cancer
por: Patel, Urvi J., et al.
Publicado: (2019)

Caplacizumab for Acute Thrombotic Thrombocytopenic Purpura
por: Katsivalis, Katherine V., et al.
Publicado: (2021)

Pegfilgrastim Biosimilars: Where Are We Now?
por: Selby, Christopher, et al.
Publicado: (2021)

Sacituzumab Govitecan for Treatment of Refractory Triple-Negative Metastatic Breast Cancer
por: Fleming, Patrick J., et al.
Publicado: (2021)

Safety around medicines for eye care
por: Khatun, Alaya, et al.
Publicado: (2021)

Belantamab Mafodotin-blmf: A Novel Antibody-Drug Conjugate for Treatment of Patients With Relapsed/Refractory Multiple Myeloma
por: Ketchum, Emily Behren, et al.
Publicado: (2022)

Tazemetostat: EZH2 Inhibitor
por: Straining, Rachael, et al.
Publicado: (2022)

Glasdegib: A Novel Hedgehog Pathway Inhibitor for Acute Myeloid Leukemia
por: Thompson, Daniel L., et al.
Publicado: (2020)

Advancements in Therapy for Bladder Cancer: Enfortumab Vedotin
por: Hanna, Kirollos S.
Publicado: (2020)

A Review of the Bruton Tyrosine Kinase Inhibitors in B-Cell Malignancies
por: Moore, Donald C., et al.
Publicado: (2021)

Voxelotor: A Hemoglobin S Polymerization Inhibitor for the Treatment of Sickle Cell Disease
por: Yenamandra, Avani, et al.
Publicado: (2020)

Encorafenib and Binimetinib Combination Therapy in Metastatic Melanoma
por: Davis, Jessica, et al.
Publicado: (2022)

The Current Landscape for METex14 Skipping Mutations in Non–Small Cell Lung Cancer
por: Desai, Alisha, et al.
Publicado: (2022)

Tebentafusp-tebn: A Novel Bispecific T-Cell Engager for Metastatic Uveal Melanoma
por: Hua, Gwen, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_f4isdq823ia0u0001u8k86v4j1